Overview
This book covers all the latest aspects related to the therapeutics of Mycobacterium. It includes therapy for the treatment of PTB, EPTB, and MDR/XDR-TB. Moreover, it also includes the treatment of NTM, challenges, and guidelines. Chapters cover the chemotherapy/drugs from traditional to most advanced drugs used for the treatment of all forms of tuberculosis and NTM. This book also includes newer therapy, immunomodulators, nanotechnology approach, immunotherapy, combinatorial therapy, Ayurvedic medicine, and repurposing of drugs. Also, discuss the challenges and opportunities for the treatment of disease. This book offers assistance to postgraduate medical students, researchers, medical practitioners, postdoctoral fellows, microbiologist, nurses, as well as public health officers working in tuberculosis control programs in understanding various modalities for the treatment of tuberculosis and drug-resistance tuberculosis.
Full Product Details
Author: Amit Singh ,
Divakar Sharma ,
Srikanth Prasad Tripathy
Publisher: Springer Verlag, Singapore
Imprint: Springer Nature
ISBN: 9789819202553
ISBN 10: 9819202558
Pages: 331
Publication Date: 20 May 2026
Audience:
Professional and scholarly
,
College/higher education
,
Professional & Vocational
,
Postgraduate, Research & Scholarly
Format: Hardback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Author Information
Dr. Amit Singh, doctorate from Division of Clinical Microbiology and Molecular Medicine, All India Institute of Medical Sciences, New Delhi. He is an assistant professor of Medical Microbiology and working in the field of infectious disease for the last 15 years. He has more than 70 peer-reviewed publications, 1 book, 15 book chapters, and 2 patents, and delivers various oral and poster presentations at national and international conferences. He was awarded with many national and international awards. He is an editorial member and reviewer of various national and international journals. Dr. Divakar Sharma, doctorate from National JALMA Institute for leprosy and other Mycobacterial disease Agra (ICMR and Jiwaji University, Gwalior), India. He has more than 16 years of experience in the field of tuberculosis research and drug resistance. He has published more than 80 articles and book chapters in international journals and books. He also edited a book for Bentham Science Publishers and Springer Nature. He also serves as an associate editor in various international journals (BMC, frontiers, Bentham Science). He is also having various national awards and fellowships. Dr. Srikanth Prasad Tripathy has a doctorate in Internal Medicine from the Madras Medical College in Chennai, India. He has worked with the Indian Council of Medical Research for 34 years and subsequently has been working as Director of Medical Research with the Dr D Y Patil Medical College, Hospital and Research Centre in Pune, India, for the last four years. His research focused on HIV, tuberculosis, and COVID, and he has more than 180 publications in national and international journals and has contributed to chapters in 12 books.
